Roth/MKM maintains Apexigen at 'neutral' with a price target of $0.64
Source link
Roth/MKM maintains Apexigen at 'neutral' with a price target of $0.64
© Reuters. FILE PHOTO: A packet of U.S. five-dollar bills is inspected at the Bureau
4/4 © Reuters. A view of newspapers on a stand at a shop, following the
© Reuters. FILE PHOTO: U.S. House Speaker Kevin McCarthy (R-CA) speaks with reporters at the
The Russian government is no longer planning to launch a regulated national cryptocurrency exchange but